home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 22, 2026
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 373 active entries

Protein Labelling Innovation (PLI) PLI Technologies PLI Advisory

Galileiweg 8
Leiden, 2333 BD
Netherlands

Phone: +31 6 41890594
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Core R&D – PLI Technologies Platform

PLI Technologies focuses on the development and integration of innovative biotechnology platforms for the controlled production of high-value biomolecules, incorporating stable isotope labelling and advanced analytical technologies.

The core R&D activities are built around three strategic pillars:

1. Biological Production & Bioconversion: Development of algae- and yeast-based platforms for the sustainable production of proteins, fatty acids and other bioactive compounds from small molecules to membrane proteins..

2. Stable Isotope Labelling: Development of technologies for the controlled ¹³C and ¹⁵N enrichment of biomass of various origin in order to produce biomolecules for applications in metabolomics, tracer studies and pharmaceutical research.

3. Advanced Analytical Technologies: Development of rapid, non-invasive IR screening methods for compositional analysis and quality control of biomass and feedstocks.

Core Innovation: Integrating biotechnology, patented stable isotope labelling and advanced analytical technologies into a unified R&D platform for the controlled production, characterization and quality control of high-value biomolecules for research and industrial applications.

Core PLI Advisory provides strategic and legal advisory services at the intersection of technology, law and investment. Its focus areas include contract drafting and negotiation, intellectual property protection, and technology assessments supporting investors in making informed go/no-go decisions. Where relevant, tax law expertise is also incorporated.

 

 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Pharmaceutical
- Research
Supplier
- General
Consulting
- Strategic
Contract
- Research
Professional
- Legal

Last update of this entry: November 22, 2026

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2026 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.